Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) FCF Margin: 2021-2025

Historic FCF Margin for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 9.69%.

  • Oncology Institute's FCF Margin fell 109100.0% to 9.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.01%, marking a year-over-year increase of 38900.0%. This contributed to the annual value of 7.71% for FY2024, which is 49000.0% up from last year.
  • Oncology Institute's FCF Margin amounted to 9.69% in Q3 2025, which was down 109100.0% from 9.52% recorded in Q2 2025.
  • Oncology Institute's FCF Margin's 5-year high stood at 2.24% during Q4 2024, with a 5-year trough of 46.28% in Q4 2021.
  • For the 5-year period, Oncology Institute's FCF Margin averaged around 14.93%, with its median value being 11.96% (2023).
  • Examining YoY changes over the last 5 years, Oncology Institute's FCF Margin showed a top increase of 238900bps in 2022 and a maximum decrease of -322800bps in 2022.
  • Oncology Institute's FCF Margin (Quarter) stood at 46.28% in 2021, then skyrocketed by 52bps to 22.39% in 2022, then skyrocketed by 75bps to 5.54% in 2023, then surged by 140bps to 2.24% in 2024, then tumbled by -533bps to 9.69% in 2025.
  • Its last three reported values are 9.69% in Q3 2025, 9.52% for Q2 2025, and 5.09% during Q1 2025.